In lung and breast cancer cells, 6‐shogaol inhibits the phosphorylation of STAT3 and decreases the CCL2 expression, preventing the effects of TADCs on tumorigenesis and metastasis in vivo and in vitro. This evidence concerns the gene CCL2 and breast cancer.